Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

129 recalls · Class III, newest first

Class III · Low risk

Liptruzet (ezetimibe and atorvastin)

This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Terminated Failed specification Merck & Co Inc NDC 66582-322-30 D-1311-2014
Class III · Low risk

Liptruzet (ezetimibe and atorvastin)

This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Terminated Failed specification Merck & Co Inc NDC 66582-321-30 D-1310-2014
Class III · Low risk

Liptruzet (ezetimibe and atorvastin)

This recall of LIPTRUZET is being initiated due to packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.

Terminated Failed specification Merck & Co Inc NDC 66582-320-30 D-1309-2014

Recalls by year